Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

21.27 -0.83 (-3.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	352,134
Open	22.47
Bid (Size)	16.66 (100)
Ask (Size)	32.00 (100)
Prev. Close	22.10
Today's Range	21.22 - 23.31
52wk Range	13.30 - 26.48
Shares Outstanding	41,151,111
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 03, 2025

Via Benzinga

What's going on in today's pre-market session ↗

August 15, 2025

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

Performance

YTD	-11.0%	-11.0%
1 Month	+0.4%	+0.4%
3 Month	+7.2%	+7.2%
6 Month	+26.8%	+26.8%
1 Year	-16.4%	-16.4%

More News

Enliven Posts Loss Beat and Cash Surge ↗

August 13, 2025

Via The Motley Fool

Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

July 02, 2025

Via Benzinga

Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’ ↗

June 23, 2025

Via Stocktwits

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 13, 2025

Via Benzinga

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 08, 2025

Via Benzinga

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

October 31, 2024

Via Benzinga

Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket

October 04, 2024

Via FinancialNewsMedia

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst ↗

September 09, 2024

Via Benzinga

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

Via InvestorPlace

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024 ↗

May 14, 2024

Via InvestorPlace

Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program ↗

April 11, 2024

Via Benzinga

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 11, 2024

Via Benzinga

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 11, 2024

Via Benzinga

Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says ↗

April 09, 2024

Via Benzinga

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 19, 2024

Via Benzinga

Wall Street Mixed As Tech Stocks Fall, Fed Meeting Begins ↗

March 19, 2024

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 19, 2024

Via Benzinga

National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday ↗

March 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 19, 2024

Via Benzinga

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023 ↗

March 14, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 16, 2024

Via Benzinga

7 A-Rated Biotech Stocks for Your August Buy List ↗

August 17, 2023

Via InvestorPlace

Frequently Asked Questions

Is Enliven Therapeutics, Inc. - Common Stock publicly traded?

Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?

Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?

The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market

What is the current price of Enliven Therapeutics, Inc. - Common Stock?

The current price of Enliven Therapeutics, Inc. - Common Stock is 21.27

When was Enliven Therapeutics, Inc. - Common Stock last traded?

The last trade of Enliven Therapeutics, Inc. - Common Stock was at 11/20/25 04:00 PM ET

What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?

The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 875.28M

How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?

Enliven Therapeutics, Inc. - Common Stock has 875M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

Price and Volume

Top News

Performance

More News

Frequently Asked Questions